nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—CYP1B1—Doxorubicin—thyroid cancer	0.0856	0.198	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0495	0.114	CbGbCtD
Caffeine—CYP3A7—Sorafenib—thyroid cancer	0.0495	0.114	CbGbCtD
Caffeine—CYP3A5—Sorafenib—thyroid cancer	0.0372	0.0858	CbGbCtD
Caffeine—CYP2C8—Sorafenib—thyroid cancer	0.0357	0.0825	CbGbCtD
Caffeine—CYP1A2—Sorafenib—thyroid cancer	0.0277	0.0639	CbGbCtD
Caffeine—Ca++ increased—Vandetanib—thyroid cancer	0.0272	0.176	CcSEcCtD
Caffeine—CYP2C9—Sorafenib—thyroid cancer	0.0249	0.0576	CbGbCtD
Caffeine—ABCB1—Sorafenib—thyroid cancer	0.0242	0.0559	CbGbCtD
Caffeine—CYP3A4—Vandetanib—thyroid cancer	0.024	0.0555	CbGbCtD
Caffeine—CYP2D6—Sorafenib—thyroid cancer	0.0228	0.0526	CbGbCtD
Caffeine—RYR1—larynx—thyroid cancer	0.0219	0.174	CbGeAlD
Caffeine—ABCB1—Doxorubicin—thyroid cancer	0.0147	0.0339	CbGbCtD
Caffeine—CYP3A4—Sorafenib—thyroid cancer	0.0145	0.0335	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—thyroid cancer	0.0138	0.0319	CbGbCtD
Caffeine—CYP3A4—Doxorubicin—thyroid cancer	0.00879	0.0203	CbGbCtD
Caffeine—Impaired healing—Vandetanib—thyroid cancer	0.00787	0.051	CcSEcCtD
Caffeine—Necrotising colitis—Epirubicin—thyroid cancer	0.00736	0.0477	CcSEcCtD
Caffeine—Necrotising colitis—Doxorubicin—thyroid cancer	0.00681	0.0441	CcSEcCtD
Caffeine—PIK3CD—neck—thyroid cancer	0.00674	0.0533	CbGeAlD
Caffeine—PIK3CB—neck—thyroid cancer	0.00588	0.0465	CbGeAlD
Caffeine—PIK3CA—neck—thyroid cancer	0.00582	0.046	CbGeAlD
Caffeine—PRKDC—saliva-secreting gland—thyroid cancer	0.00561	0.0443	CbGeAlD
Caffeine—Haemoglobin decreased—Vandetanib—thyroid cancer	0.00495	0.032	CcSEcCtD
Caffeine—Hypercalcaemia—Vandetanib—thyroid cancer	0.0049	0.0317	CcSEcCtD
Caffeine—PIK3CB—saliva-secreting gland—thyroid cancer	0.00459	0.0363	CbGeAlD
Caffeine—PRKDC—trachea—thyroid cancer	0.00432	0.0342	CbGeAlD
Caffeine—Cerebral haemorrhage—Sorafenib—thyroid cancer	0.00415	0.0268	CcSEcCtD
Caffeine—ATM—thyroid gland—thyroid cancer	0.00362	0.0286	CbGeAlD
Caffeine—Creatinine increased—Vandetanib—thyroid cancer	0.00358	0.0232	CcSEcCtD
Caffeine—PIK3CB—trachea—thyroid cancer	0.00354	0.028	CbGeAlD
Caffeine—PRKDC—thyroid gland—thyroid cancer	0.00342	0.0271	CbGeAlD
Caffeine—Haemoglobin decreased—Sorafenib—thyroid cancer	0.00334	0.0216	CcSEcCtD
Caffeine—ATM—head—thyroid cancer	0.00321	0.0254	CbGeAlD
Caffeine—PIK3CD—thyroid gland—thyroid cancer	0.00321	0.0254	CbGeAlD
Caffeine—Sepsis—Vandetanib—thyroid cancer	0.00295	0.0191	CcSEcCtD
Caffeine—PIK3CD—head—thyroid cancer	0.00285	0.0225	CbGeAlD
Caffeine—PIK3CB—thyroid gland—thyroid cancer	0.0028	0.0221	CbGeAlD
Caffeine—RYR1—thyroid gland—thyroid cancer	0.00277	0.0219	CbGeAlD
Caffeine—PIK3CA—thyroid gland—thyroid cancer	0.00277	0.0219	CbGeAlD
Caffeine—ADORA2B—trachea—thyroid cancer	0.00258	0.0204	CbGeAlD
Caffeine—Hypoglycaemia—Vandetanib—thyroid cancer	0.00253	0.0164	CcSEcCtD
Caffeine—PIK3CB—head—thyroid cancer	0.00248	0.0196	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Vandetanib—thyroid cancer	0.00247	0.016	CcSEcCtD
Caffeine—PIK3CA—head—thyroid cancer	0.00246	0.0194	CbGeAlD
Caffeine—RYR1—head—thyroid cancer	0.00246	0.0194	CbGeAlD
Caffeine—ADORA1—saliva-secreting gland—thyroid cancer	0.0024	0.019	CbGeAlD
Caffeine—Blood creatinine increased—Vandetanib—thyroid cancer	0.00232	0.015	CcSEcCtD
Caffeine—Dry skin—Vandetanib—thyroid cancer	0.00227	0.0147	CcSEcCtD
Caffeine—ATM—lymph node—thyroid cancer	0.00225	0.0178	CbGeAlD
Caffeine—Gastritis—Vandetanib—thyroid cancer	0.00219	0.0142	CcSEcCtD
Caffeine—PRKDC—lymph node—thyroid cancer	0.00213	0.0168	CbGeAlD
Caffeine—PIK3CD—lymph node—thyroid cancer	0.00199	0.0158	CbGeAlD
Caffeine—Hyperglycaemia—Vandetanib—thyroid cancer	0.00193	0.0125	CcSEcCtD
Caffeine—Infestation NOS—Vandetanib—thyroid cancer	0.0019	0.0123	CcSEcCtD
Caffeine—Infestation—Vandetanib—thyroid cancer	0.0019	0.0123	CcSEcCtD
Caffeine—Renal failure—Vandetanib—thyroid cancer	0.00187	0.0121	CcSEcCtD
Caffeine—ADORA2B—head—thyroid cancer	0.00181	0.0143	CbGeAlD
Caffeine—PDE4B—saliva-secreting gland—thyroid cancer	0.00177	0.014	CbGeAlD
Caffeine—PIK3CB—lymph node—thyroid cancer	0.00174	0.0138	CbGeAlD
Caffeine—PIK3CA—lymph node—thyroid cancer	0.00172	0.0136	CbGeAlD
Caffeine—Haemoglobin—Vandetanib—thyroid cancer	0.00172	0.0111	CcSEcCtD
Caffeine—Haemorrhage—Vandetanib—thyroid cancer	0.00171	0.0111	CcSEcCtD
Caffeine—Cardiac disorder—Vandetanib—thyroid cancer	0.00159	0.0103	CcSEcCtD
Caffeine—Dry skin—Sorafenib—thyroid cancer	0.00153	0.00989	CcSEcCtD
Caffeine—ADORA2A—head—thyroid cancer	0.0015	0.0119	CbGeAlD
Caffeine—Malnutrition—Vandetanib—thyroid cancer	0.00149	0.00963	CcSEcCtD
Caffeine—Gastritis—Sorafenib—thyroid cancer	0.00148	0.00955	CcSEcCtD
Caffeine—ADORA1—thyroid gland—thyroid cancer	0.00146	0.0116	CbGeAlD
Caffeine—PDE4B—trachea—thyroid cancer	0.00137	0.0108	CbGeAlD
Caffeine—ADORA1—head—thyroid cancer	0.0013	0.0103	CbGeAlD
Caffeine—Convulsion—Vandetanib—thyroid cancer	0.00129	0.00835	CcSEcCtD
Caffeine—Hypertension—Vandetanib—thyroid cancer	0.00129	0.00832	CcSEcCtD
Caffeine—Infestation NOS—Sorafenib—thyroid cancer	0.00128	0.00832	CcSEcCtD
Caffeine—Infestation—Sorafenib—thyroid cancer	0.00128	0.00832	CcSEcCtD
Caffeine—Renal failure—Sorafenib—thyroid cancer	0.00126	0.00817	CcSEcCtD
Caffeine—Hypercalcaemia—Epirubicin—thyroid cancer	0.00122	0.00791	CcSEcCtD
Caffeine—Infection—Vandetanib—thyroid cancer	0.00121	0.00781	CcSEcCtD
Caffeine—Nervous system disorder—Vandetanib—thyroid cancer	0.00119	0.00771	CcSEcCtD
Caffeine—Skin disorder—Vandetanib—thyroid cancer	0.00118	0.00764	CcSEcCtD
Caffeine—Haemoglobin—Sorafenib—thyroid cancer	0.00116	0.0075	CcSEcCtD
Caffeine—Haemorrhage—Sorafenib—thyroid cancer	0.00115	0.00747	CcSEcCtD
Caffeine—Hypercalcaemia—Doxorubicin—thyroid cancer	0.00113	0.00732	CcSEcCtD
Caffeine—Dyspnoea—Vandetanib—thyroid cancer	0.00108	0.00701	CcSEcCtD
Caffeine—PDE4B—thyroid gland—thyroid cancer	0.00108	0.00857	CbGeAlD
Caffeine—Cardiac disorder—Sorafenib—thyroid cancer	0.00107	0.00693	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00105	0.00679	CcSEcCtD
Caffeine—Immune system disorder—Sorafenib—thyroid cancer	0.00104	0.00674	CcSEcCtD
Caffeine—Malnutrition—Sorafenib—thyroid cancer	0.001	0.0065	CcSEcCtD
Caffeine—PDE4B—head—thyroid cancer	0.000961	0.0076	CbGeAlD
Caffeine—CYP1B1—thyroid gland—thyroid cancer	0.000928	0.00734	CbGeAlD
Caffeine—ADORA1—lymph node—thyroid cancer	0.000909	0.00719	CbGeAlD
Caffeine—Creatinine increased—Epirubicin—thyroid cancer	0.000892	0.00577	CcSEcCtD
Caffeine—Hypertension—Sorafenib—thyroid cancer	0.000867	0.00561	CcSEcCtD
Caffeine—CYP1A1—trachea—thyroid cancer	0.000829	0.00656	CbGeAlD
Caffeine—Creatinine increased—Doxorubicin—thyroid cancer	0.000825	0.00534	CcSEcCtD
Caffeine—CYP1B1—head—thyroid cancer	0.000823	0.00651	CbGeAlD
Caffeine—Infection—Sorafenib—thyroid cancer	0.000814	0.00527	CcSEcCtD
Caffeine—Nervous system disorder—Sorafenib—thyroid cancer	0.000804	0.0052	CcSEcCtD
Caffeine—Skin disorder—Sorafenib—thyroid cancer	0.000796	0.00515	CcSEcCtD
Caffeine—Rash—Vandetanib—thyroid cancer	0.000766	0.00496	CcSEcCtD
Caffeine—Dermatitis—Vandetanib—thyroid cancer	0.000765	0.00495	CcSEcCtD
Caffeine—Pulmonary oedema—Epirubicin—thyroid cancer	0.000756	0.00489	CcSEcCtD
Caffeine—Sepsis—Epirubicin—thyroid cancer	0.000737	0.00477	CcSEcCtD
Caffeine—Dyspnoea—Sorafenib—thyroid cancer	0.000731	0.00473	CcSEcCtD
Caffeine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000707	0.00458	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000699	0.00452	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—thyroid cancer	0.000682	0.00441	CcSEcCtD
Caffeine—PDE4B—lymph node—thyroid cancer	0.000673	0.00532	CbGeAlD
Caffeine—CYP1A2—thyroid gland—thyroid cancer	0.000665	0.00526	CbGeAlD
Caffeine—CYP1A1—thyroid gland—thyroid cancer	0.000656	0.00519	CbGeAlD
Caffeine—Hypoglycaemia—Epirubicin—thyroid cancer	0.000631	0.00409	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000616	0.00399	CcSEcCtD
Caffeine—Hypersensitivity—Sorafenib—thyroid cancer	0.000604	0.00391	CcSEcCtD
Caffeine—CYP2E1—thyroid gland—thyroid cancer	0.000598	0.00473	CbGeAlD
Caffeine—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000584	0.00378	CcSEcCtD
Caffeine—CYP1A1—head—thyroid cancer	0.000582	0.0046	CbGeAlD
Caffeine—Blood creatinine increased—Epirubicin—thyroid cancer	0.000577	0.00374	CcSEcCtD
Caffeine—CYP1B1—lymph node—thyroid cancer	0.000576	0.00456	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.00057	0.00369	CcSEcCtD
Caffeine—Dry skin—Epirubicin—thyroid cancer	0.000565	0.00366	CcSEcCtD
Caffeine—Gastritis—Epirubicin—thyroid cancer	0.000545	0.00353	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000534	0.00346	CcSEcCtD
Caffeine—CYP2E1—head—thyroid cancer	0.000531	0.0042	CbGeAlD
Caffeine—Dry skin—Doxorubicin—thyroid cancer	0.000523	0.00338	CcSEcCtD
Caffeine—Rash—Sorafenib—thyroid cancer	0.000517	0.00334	CcSEcCtD
Caffeine—Dermatitis—Sorafenib—thyroid cancer	0.000516	0.00334	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—thyroid cancer	0.000505	0.00327	CcSEcCtD
Caffeine—Hyperglycaemia—Epirubicin—thyroid cancer	0.00048	0.00311	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—thyroid cancer	0.000475	0.00307	CcSEcCtD
Caffeine—Infestation—Epirubicin—thyroid cancer	0.000475	0.00307	CcSEcCtD
Caffeine—Renal failure—Epirubicin—thyroid cancer	0.000467	0.00302	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000444	0.00288	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—thyroid cancer	0.000439	0.00284	CcSEcCtD
Caffeine—Infestation—Doxorubicin—thyroid cancer	0.000439	0.00284	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—thyroid cancer	0.000432	0.0028	CcSEcCtD
Caffeine—ABCB1—trachea—thyroid cancer	0.000431	0.00341	CbGeAlD
Caffeine—Haemoglobin—Epirubicin—thyroid cancer	0.000428	0.00277	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—thyroid cancer	0.000426	0.00276	CcSEcCtD
Caffeine—CYP2D6—head—thyroid cancer	0.00042	0.00332	CbGeAlD
Caffeine—CYP1A1—lymph node—thyroid cancer	0.000408	0.00322	CbGeAlD
Caffeine—Haemoglobin—Doxorubicin—thyroid cancer	0.000396	0.00257	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—thyroid cancer	0.000396	0.00256	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—thyroid cancer	0.000394	0.00255	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—thyroid cancer	0.000385	0.00249	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—thyroid cancer	0.000371	0.0024	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000366	0.00237	CcSEcCtD
Caffeine—Nervousness—Epirubicin—thyroid cancer	0.00036	0.00233	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—thyroid cancer	0.000356	0.00231	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—thyroid cancer	0.000343	0.00222	CcSEcCtD
Caffeine—Agitation—Epirubicin—thyroid cancer	0.000341	0.00221	CcSEcCtD
Caffeine—ABCB1—thyroid gland—thyroid cancer	0.000341	0.0027	CbGeAlD
Caffeine—Nervousness—Doxorubicin—thyroid cancer	0.000333	0.00216	CcSEcCtD
Caffeine—Convulsion—Epirubicin—thyroid cancer	0.000321	0.00208	CcSEcCtD
Caffeine—Hypertension—Epirubicin—thyroid cancer	0.00032	0.00207	CcSEcCtD
Caffeine—Agitation—Doxorubicin—thyroid cancer	0.000316	0.00204	CcSEcCtD
Caffeine—ABCB1—head—thyroid cancer	0.000302	0.00239	CbGeAlD
Caffeine—Infection—Epirubicin—thyroid cancer	0.000301	0.00195	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—thyroid cancer	0.000297	0.00193	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—thyroid cancer	0.000297	0.00192	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—thyroid cancer	0.000296	0.00192	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—thyroid cancer	0.000296	0.00191	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—thyroid cancer	0.000294	0.0019	CcSEcCtD
Caffeine—Infection—Doxorubicin—thyroid cancer	0.000278	0.0018	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000275	0.00178	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—thyroid cancer	0.000273	0.00177	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—thyroid cancer	0.000272	0.00176	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—thyroid cancer	0.00027	0.00175	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000261	0.00169	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—thyroid cancer	0.00025	0.00162	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000242	0.00157	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—thyroid cancer	0.000223	0.00144	CcSEcCtD
Caffeine—ABCB1—lymph node—thyroid cancer	0.000212	0.00167	CbGeAlD
Caffeine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000206	0.00134	CcSEcCtD
Caffeine—Rash—Epirubicin—thyroid cancer	0.000191	0.00124	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—thyroid cancer	0.000191	0.00123	CcSEcCtD
Caffeine—Rash—Doxorubicin—thyroid cancer	0.000177	0.00114	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—thyroid cancer	0.000177	0.00114	CcSEcCtD
Caffeine—CYP1B1—Metabolism—SLC5A5—thyroid cancer	2.22e-05	7.76e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—NRAS—thyroid cancer	2.22e-05	7.76e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TERT—thyroid cancer	2.22e-05	7.76e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.21e-05	7.74e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—NRAS—thyroid cancer	2.2e-05	7.69e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TERT—thyroid cancer	2.19e-05	7.66e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—KRAS—thyroid cancer	2.19e-05	7.66e-05	CbGpPWpGaD
Caffeine—PIK3CB—Adaptive Immune System—AKT1—thyroid cancer	2.16e-05	7.55e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—NRAS—thyroid cancer	2.15e-05	7.51e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.14e-05	7.47e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HIF1A—thyroid cancer	2.12e-05	7.42e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—PTEN—thyroid cancer	2.1e-05	7.33e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HIF1A—thyroid cancer	2.1e-05	7.33e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—BRAF—thyroid cancer	2.09e-05	7.29e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.08e-05	7.27e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TERT—thyroid cancer	2.08e-05	7.25e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—BRAF—thyroid cancer	2.07e-05	7.22e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.07e-05	7.22e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—NRAS—thyroid cancer	2.03e-05	7.09e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HPGD—thyroid cancer	2.03e-05	7.09e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PPARG—thyroid cancer	2.02e-05	7.05e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—PTEN—thyroid cancer	2.02e-05	7.05e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PTGS2—thyroid cancer	2.02e-05	7.04e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—HRAS—thyroid cancer	2.01e-05	7.01e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—KRAS—thyroid cancer	2e-05	7e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	2e-05	7e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HIF1A—thyroid cancer	1.99e-05	6.94e-05	CbGpPWpGaD
Caffeine—PIK3CA—Hemostasis—AKT1—thyroid cancer	1.97e-05	6.88e-05	CbGpPWpGaD
Caffeine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.96e-05	6.85e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CHST14—thyroid cancer	1.94e-05	6.78e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—TPR—thyroid cancer	1.94e-05	6.77e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—TPR—thyroid cancer	1.93e-05	6.76e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—HRAS—thyroid cancer	1.93e-05	6.74e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.93e-05	6.73e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—KRAS—thyroid cancer	1.91e-05	6.68e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRG1—thyroid cancer	1.91e-05	6.67e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.91e-05	6.66e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	1.9e-05	6.65e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTGS2—thyroid cancer	1.9e-05	6.63e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—KRAS—thyroid cancer	1.89e-05	6.61e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—NRAS—thyroid cancer	1.87e-05	6.54e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—NRAS—thyroid cancer	1.87e-05	6.53e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—RXRA—thyroid cancer	1.87e-05	6.52e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—HRAS—thyroid cancer	1.86e-05	6.51e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—KRAS—thyroid cancer	1.85e-05	6.46e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—NRAS—thyroid cancer	1.85e-05	6.46e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—TPR—thyroid cancer	1.83e-05	6.38e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.81e-05	6.34e-05	CbGpPWpGaD
Caffeine—PIK3CD—GPCR downstream signaling—AKT1—thyroid cancer	1.81e-05	6.33e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	1.8e-05	6.28e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—PTEN—thyroid cancer	1.79e-05	6.26e-05	CbGpPWpGaD
Caffeine—PIK3CA—Innate Immune System—AKT1—thyroid cancer	1.77e-05	6.19e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—BRAF—thyroid cancer	1.76e-05	6.14e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—PTEN—thyroid cancer	1.76e-05	6.14e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—NRAS—thyroid cancer	1.75e-05	6.11e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—CCND1—thyroid cancer	1.75e-05	6.1e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—KRAS—thyroid cancer	1.75e-05	6.1e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—BRAF—thyroid cancer	1.74e-05	6.07e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TERT—thyroid cancer	1.71e-05	5.99e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—HRAS—thyroid cancer	1.7e-05	5.95e-05	CbGpPWpGaD
Caffeine—PIK3CA—Adaptive Immune System—AKT1—thyroid cancer	1.7e-05	5.95e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—PTEN—thyroid cancer	1.69e-05	5.89e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—RXRA—thyroid cancer	1.68e-05	5.88e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—TPR—thyroid cancer	1.67e-05	5.85e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—PTEN—thyroid cancer	1.65e-05	5.78e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.65e-05	5.76e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling by GPCR—AKT1—thyroid cancer	1.65e-05	5.75e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.65e-05	5.75e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—BRAF—thyroid cancer	1.64e-05	5.75e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.64e-05	5.74e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HIF1A—thyroid cancer	1.64e-05	5.73e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.63e-05	5.69e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—HRAS—thyroid cancer	1.62e-05	5.67e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—KRAS—thyroid cancer	1.61e-05	5.63e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—KRAS—thyroid cancer	1.61e-05	5.62e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—HRAS—thyroid cancer	1.61e-05	5.62e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—NRAS—thyroid cancer	1.6e-05	5.58e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—KRAS—thyroid cancer	1.59e-05	5.56e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTGS2—thyroid cancer	1.59e-05	5.55e-05	CbGpPWpGaD
Caffeine—PIK3CB—GPCR downstream signaling—AKT1—thyroid cancer	1.58e-05	5.52e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—HRAS—thyroid cancer	1.57e-05	5.49e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HPGD—thyroid cancer	1.57e-05	5.47e-05	CbGpPWpGaD
Caffeine—ADORA2B—GPCR downstream signaling—AKT1—thyroid cancer	1.56e-05	5.47e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—CCND1—thyroid cancer	1.52e-05	5.32e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—CCND1—thyroid cancer	1.51e-05	5.27e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—KRAS—thyroid cancer	1.51e-05	5.26e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—NRAS—thyroid cancer	1.5e-05	5.26e-05	CbGpPWpGaD
Caffeine—PIK3CD—Immune System—AKT1—thyroid cancer	1.5e-05	5.25e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.49e-05	5.22e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—HRAS—thyroid cancer	1.48e-05	5.18e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—NRAS—thyroid cancer	1.48e-05	5.16e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—PTEN—thyroid cancer	1.47e-05	5.14e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TPR—thyroid cancer	1.46e-05	5.1e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.46e-05	5.1e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—PTEN—thyroid cancer	1.46e-05	5.09e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.45e-05	5.07e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.45e-05	5.06e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—NRAS—thyroid cancer	1.44e-05	5.05e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.44e-05	5.02e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling by GPCR—AKT1—thyroid cancer	1.43e-05	5.01e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling by GPCR—AKT1—thyroid cancer	1.42e-05	4.96e-05	CbGpPWpGaD
Caffeine—PIK3CD—Disease—AKT1—thyroid cancer	1.39e-05	4.85e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—PTEN—thyroid cancer	1.39e-05	4.84e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—KRAS—thyroid cancer	1.38e-05	4.81e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TPR—thyroid cancer	1.38e-05	4.8e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—HRAS—thyroid cancer	1.37e-05	4.79e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—HRAS—thyroid cancer	1.37e-05	4.78e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.37e-05	4.78e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TPR—thyroid cancer	1.36e-05	4.76e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—BRAF—thyroid cancer	1.36e-05	4.74e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.35e-05	4.73e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—HRAS—thyroid cancer	1.35e-05	4.72e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.34e-05	4.69e-05	CbGpPWpGaD
Caffeine—ADORA1—GPCR downstream signaling—AKT1—thyroid cancer	1.33e-05	4.65e-05	CbGpPWpGaD
Caffeine—PDE4B—GPCR downstream signaling—AKT1—thyroid cancer	1.31e-05	4.59e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—NRAS—thyroid cancer	1.31e-05	4.58e-05	CbGpPWpGaD
Caffeine—PIK3CB—Immune System—AKT1—thyroid cancer	1.31e-05	4.58e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—NRAS—thyroid cancer	1.3e-05	4.54e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—KRAS—thyroid cancer	1.29e-05	4.52e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—CCND1—thyroid cancer	1.28e-05	4.48e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.28e-05	4.48e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—HRAS—thyroid cancer	1.28e-05	4.47e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—KRAS—thyroid cancer	1.27e-05	4.44e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—CCND1—thyroid cancer	1.27e-05	4.43e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.25e-05	4.38e-05	CbGpPWpGaD
Caffeine—PIK3CA—GPCR downstream signaling—AKT1—thyroid cancer	1.24e-05	4.35e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—KRAS—thyroid cancer	1.24e-05	4.34e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PTEN—thyroid cancer	1.24e-05	4.33e-05	CbGpPWpGaD
Caffeine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.23e-05	4.3e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PTEN—thyroid cancer	1.22e-05	4.28e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—RXRA—thyroid cancer	1.22e-05	4.26e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—RXRA—thyroid cancer	1.22e-05	4.25e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.22e-05	4.25e-05	CbGpPWpGaD
Caffeine—PIK3CB—Disease—AKT1—thyroid cancer	1.21e-05	4.23e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling by GPCR—AKT1—thyroid cancer	1.21e-05	4.22e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—CCND1—thyroid cancer	1.2e-05	4.19e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling by GPCR—AKT1—thyroid cancer	1.19e-05	4.17e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PPARG—thyroid cancer	1.18e-05	4.12e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.17e-05	4.1e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—HRAS—thyroid cancer	1.17e-05	4.09e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TPR—thyroid cancer	1.16e-05	4.07e-05	CbGpPWpGaD
Caffeine—PIK3CD—Metabolism—AKT1—thyroid cancer	1.16e-05	4.06e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—PTEN—thyroid cancer	1.16e-05	4.05e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—TP53—thyroid cancer	1.15e-05	4.02e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—RXRA—thyroid cancer	1.15e-05	4.01e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.15e-05	4e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling by GPCR—AKT1—thyroid cancer	1.13e-05	3.95e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—KRAS—thyroid cancer	1.13e-05	3.94e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—KRAS—thyroid cancer	1.12e-05	3.91e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.12e-05	3.9e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—NRAS—thyroid cancer	1.1e-05	3.86e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—HRAS—thyroid cancer	1.1e-05	3.85e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.09e-05	3.82e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—NRAS—thyroid cancer	1.09e-05	3.81e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—HRAS—thyroid cancer	1.08e-05	3.77e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PPARG—thyroid cancer	1.06e-05	3.71e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—HRAS—thyroid cancer	1.06e-05	3.69e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—RXRA—thyroid cancer	1.05e-05	3.68e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.04e-05	3.63e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	3.61e-05	CbGpPWpGaD
Caffeine—PIK3CA—Immune System—AKT1—thyroid cancer	1.03e-05	3.61e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.03e-05	3.6e-05	CbGpPWpGaD
Caffeine—ADORA2A—GPCR downstream signaling—AKT1—thyroid cancer	1.03e-05	3.59e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.02e-05	3.58e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.02e-05	3.57e-05	CbGpPWpGaD
Caffeine—PIK3CB—Metabolism—AKT1—thyroid cancer	1.01e-05	3.54e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—TP53—thyroid cancer	1e-05	3.5e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—TP53—thyroid cancer	9.94e-06	3.47e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—CCND1—thyroid cancer	9.91e-06	3.46e-05	CbGpPWpGaD
Caffeine—PIK3CD—Signaling Pathways—AKT1—thyroid cancer	9.72e-06	3.4e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—HRAS—thyroid cancer	9.59e-06	3.35e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.56e-06	3.34e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PTEN—thyroid cancer	9.56e-06	3.34e-05	CbGpPWpGaD
Caffeine—PIK3CA—Disease—AKT1—thyroid cancer	9.53e-06	3.33e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—KRAS—thyroid cancer	9.51e-06	3.32e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—HRAS—thyroid cancer	9.51e-06	3.32e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—KRAS—thyroid cancer	9.4e-06	3.28e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling by GPCR—AKT1—thyroid cancer	9.33e-06	3.26e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTGS2—thyroid cancer	9.27e-06	3.24e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—RXRA—thyroid cancer	9.18e-06	3.21e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TPR—thyroid cancer	8.99e-06	3.14e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—thyroid cancer	8.89e-06	3.11e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	8.84e-06	3.09e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	8.72e-06	3.05e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—RXRA—thyroid cancer	8.65e-06	3.02e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—RXRA—thyroid cancer	8.57e-06	3e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—NRAS—thyroid cancer	8.53e-06	2.98e-05	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—thyroid cancer	8.47e-06	2.96e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—thyroid cancer	8.45e-06	2.95e-05	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—thyroid cancer	8.39e-06	2.93e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—thyroid cancer	8.36e-06	2.92e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—thyroid cancer	8.35e-06	2.92e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.34e-06	2.91e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.17e-06	2.85e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—thyroid cancer	8.08e-06	2.82e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—thyroid cancer	8.08e-06	2.82e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—thyroid cancer	7.99e-06	2.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—thyroid cancer	7.98e-06	2.79e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—thyroid cancer	7.91e-06	2.76e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PPARG—thyroid cancer	7.7e-06	2.69e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PPARG—thyroid cancer	7.68e-06	2.68e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—thyroid cancer	7.56e-06	2.64e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—thyroid cancer	7.34e-06	2.57e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—RXRA—thyroid cancer	7.33e-06	2.56e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—thyroid cancer	7.29e-06	2.55e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARG—thyroid cancer	7.26e-06	2.53e-05	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—thyroid cancer	7.14e-06	2.49e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.13e-06	2.49e-05	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—thyroid cancer	7.05e-06	2.46e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	6.73e-06	2.35e-05	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—thyroid cancer	6.68e-06	2.33e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARG—thyroid cancer	6.65e-06	2.32e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—thyroid cancer	6.53e-06	2.28e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—thyroid cancer	6.24e-06	2.18e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—thyroid cancer	6.05e-06	2.11e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—thyroid cancer	6.04e-06	2.11e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARG—thyroid cancer	5.79e-06	2.02e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—thyroid cancer	5.71e-06	1.99e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—RXRA—thyroid cancer	5.65e-06	1.98e-05	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—thyroid cancer	5.51e-06	1.93e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARG—thyroid cancer	5.46e-06	1.91e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARG—thyroid cancer	5.41e-06	1.89e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—thyroid cancer	5.28e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—thyroid cancer	5.27e-06	1.84e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—thyroid cancer	5.23e-06	1.83e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—thyroid cancer	4.98e-06	1.74e-05	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—thyroid cancer	4.66e-06	1.63e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARG—thyroid cancer	4.63e-06	1.62e-05	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—thyroid cancer	4.56e-06	1.59e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—thyroid cancer	4.56e-06	1.59e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—thyroid cancer	4.3e-06	1.5e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—thyroid cancer	4.26e-06	1.49e-05	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—thyroid cancer	4.2e-06	1.47e-05	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—thyroid cancer	3.98e-06	1.39e-05	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—thyroid cancer	3.75e-06	1.31e-05	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—thyroid cancer	3.71e-06	1.3e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.64e-06	1.27e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARG—thyroid cancer	3.57e-06	1.25e-05	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—thyroid cancer	3.17e-06	1.11e-05	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—thyroid cancer	3.04e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—thyroid cancer	3.04e-06	1.06e-05	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—thyroid cancer	2.87e-06	1e-05	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.81e-06	9.81e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—thyroid cancer	2.63e-06	9.19e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—thyroid cancer	2.45e-06	8.56e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—thyroid cancer	2.29e-06	8e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—thyroid cancer	2.16e-06	7.54e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—thyroid cancer	2.14e-06	7.48e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—thyroid cancer	1.83e-06	6.39e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.41e-06	4.93e-06	CbGpPWpGaD
